Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Day One Biopharmaceuticals (DAWN) Net Margin (2024 - 2025)

Day One Biopharmaceuticals (DAWN) has disclosed Net Margin for 2 consecutive years, with 47.07% as the latest value for Q4 2025.

  • For Q4 2025, Net Margin rose 17790.0% year-over-year to 47.07%; the TTM value through Dec 2025 reached 70.33%, up 8572.0%, while the annual FY2025 figure was 70.35%, 243.0% up from the prior year.
  • Net Margin was 47.07% for Q4 2025 at Day One Biopharmaceuticals, up from 49.48% in the prior quarter.
  • The five-year high for Net Margin was 38.22% in Q3 2024, with the low at 1372.03% in Q2 2024.